Holen Sie sich die Stockscreener-App
5.71
3.63%
0.20
Handel nachbörslich:
5.71
Emergent Biosolutions Inc Aktie (EBS) Neueste Nachrichten
India-based Syngene acquires its first US biologics site - Manufacturing Dive
Emergent BioSolutions to invest in Rocketvax for vaccine developments - MSN
Emergent BioSolutions to sell Baltimore-Bayview manufacturing site for $36.5M - MSN
Emergent signs financial investment agreement with Swiss Rockets - Yahoo Finance
Emergent BioSolutions Reinforces its Commitment to Expanding Access to NARCAN® Nasal Spray by Supporting Organizations with New Opioid Overdose Preparedness Programs - The Manila Times
Emergent BioSolutions Reinforces its Commitment to Expanding Access to NARCAN® Nasal Spray by ... - The Bakersfield Californian
First OTC Narcan Program Targets High-Risk Construction Workers to Combat Overdose Crisis - StockTitan
Emergent BioSolutions director Fowler sells $204,050 in stock By Investing.com - Investing.com Australia
Emergent BioSolutions director Fowler sells $204,050 in stock - Investing.com India
Emergent BioSolutions director Zoon sells $57,300 in stock - Investing.com
Emergent Bio and Rocketvax in investment deal and partnership - The Pharma Letter
Emergent BioSolutions and Rocketvax Announce Investment Agreement - Contract Pharma
Emergent Biosolutions And Rocketvax Announce Investment Agreement And Pursuit Of A Strategic Relationship For Next-Generation Product Candidates - Marketscreener.com
Emergent BioSolutions to Invest in Swiss Rockets, Rocketvax -March 12, 2025 at 08:40 am EDT - Marketscreener.com
Emergent BioSolutions, Rocketvax announce investment agreement - TipRanks
Emergent BioSolutions and Rocketvax Ltd Announce Strategic Investment and Partnership to Advance Next-Generation Vaccine Development - Nasdaq
Emergent BioSolutions and Rocketvax Announce Investment - GlobeNewswire
Emergent BioSolutions and Rocketvax Announce Investment Agreement and Pursuit of a Strategic Relationship for Next-Generation Product Candidates - GlobeNewswire Inc.
Rhumbline Advisers Trims Stock Position in Emergent BioSolutions Inc. (NYSE:EBS) - Defense World
Syngene buys its first manufacturing facility in US for USD36.5 million - Medical Dialogues
Emergent BioSolutions Sells Baltimore Facility to Syngene - TipRanks
Gaithersburg's Emergent BioSolutions to sell Baltimore plant for $36.5M - The Business Journals
Drug manufacturer to sell Baltimore plant for $36.5M - The Business Journals
Emergent BioSolutions sells Baltimore facility to Syngene By Investing.com - Investing.com Canada
Emergent BioSolutions drops after Syngene buys co's unit for $36.5 mln - TradingView
India's Syngene International acquires first US biologics facility for $36.5 million - Yahoo Finance
Emergent to Sell Baltimore-Bayview Facility for $36.5 Million -March 10, 2025 at 10:28 am EDT - Marketscreener.com
Emergent BioSolutions sells Baltimore facility to Syngene - Investing.com
Emergent BioSolutions Announces Sale of Baltimore-Bayview Manufacturing Site to Syngene International - The Manila Times
Emergent BioSolutions to sell Baltimore-Bayview facility for $36.5M - TipRanks
Emergent BioSolutions’ (EBS) Buy Rating Reiterated at HC Wainwright - Defense World
Q1 Earnings Estimate for EBS Issued By HC Wainwright - Defense World
Emergent BioSolutions Inc. (NYSE:EBS) Consensus Forecasts Have Become A Little Darker Since Its Latest Report - Yahoo Finance
Is Emergent BioSolutions (NYSE:EBS) Weighed On By Its Debt Load? - Simply Wall St
Emergent BioSolutions’ Earnings Call: Balancing Achievements and Challenges - TipRanks
Emergent BioSolutions Reports Strong 2024 Financial Turnaround - MSN
Where Emergent BioSolutions Stands With Analysts - Benzinga
Emergent BioSolutions Inc. (NYSE:EBS) Q4 2024 Earnings Call Transcript - Insider Monkey
H.C. Wainwright maintains Buy rating on Emergent BioSolutions stock By Investing.com - Investing.com UK
Emergent Bio's Q4 Revenue Plunges Nearly 30%, Forecasts 18% To 28% Drop For 2025 - Nasdaq
Emergent BioSolutions Inc. SEC 10-K Report - TradingView
(EBS) Trading Signals - Stock Traders Daily
Emergent BioSolutions Inc (EBS) Q4 2024 Earnings Call Highlights: Strategic Advancements Amid ... By GuruFocus - Investing.com Canada
Emergent BioSolutions Stock Sinks As Q4 Revenue Plunges 30%, But Retail Clings To Profit Swing - MSN
Emergent Biosolutions: Q4 Earnings Snapshot - Midland Daily News
Emergent BioSolutions (EBS) Q4 2024 Earnings Call Transcript - AOL
Emergent BioSolutions Inc Q4 2024 Earnings: EPS of -$0.58 Misses Estimate, Revenue Falls Short at $194.7 Million - GuruFocus.com
Emergent BioSolutions Inc (EBS) Q4 2024 Earnings Call Highlights: Strategic Advancements Amid ... - Yahoo Finance
Emergent BioSolutions Inc reports results for the quarter ended December 31Earnings Summary - TradingView
EMERGENT BIOSOLUTIONS Earnings Results: $EBS Reports Quarterly Earnings - Nasdaq
Emergent BioSolutions Swings to Q4 Earnings, Revenue Declines -- Shares Fall After Hours - Marketscreener.com
Emergent BioSolutions tumbles 8% as Q4 revenue, 2025 guidance disappoints - Seeking Alpha
Emergent Biosolutions (EBS) Q4 Earnings Top Estimates - Yahoo Finance
After-hours movers: Okta, GitLab, New Fortress Energy, Emergent BioSolutions - Investing.com Australia
Emergent BioSolutions falls after reporting downbeat quarterly revenue - TradingView
Emergent Biosolutions earnings beat by $0.46, revenue fell short of estimates - Investing.com Canada
1.26%
0.07%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):